PeptiDream
- Country
- 🇯🇵Japan
- Ownership
- -
- Employees
- 603
- Market Cap
- $2.3B
- Introduction
PeptiDream Inc is a biopharmaceutical company, engaged in the research and development of new pharmaceutical candidates. It discovers constrained peptides, small molecules, and peptide-drug conjugate therapeutics using its Peptide Discovery Platform System. The company aspires to be a leader in drug discovery and development to address unmet medical needs and improve the quality of life of patients worldwide.
Roche Expands Molecular Glue Portfolio with $2 Billion Monte Rosa Partnership
Roche has signed a $2 billion partnership with Monte Rosa Therapeutics, including a $50 million upfront payment, to develop molecular glue therapies targeting previously "undruggable" proteins in cancer and neurological diseases.
Curium and PDRadiopharma Collaborate to Advance PSMA-Targeting Theranostics in Japan
Curium and PDRadiopharma are partnering to advance clinical development and commercialization of 177Lu-PSMA-I&T and 64Cu-PSMA-I&T theranostics in Japan.